Shanghai InnoStar Bio-tech Co., Ltd. (SHA:688710)
56.80
-1.80 (-3.07%)
At close: Feb 2, 2026
Shanghai InnoStar Bio-tech Company Description
Shanghai InnoStar Bio-tech Co., Ltd. provides drug research and development services in China and internationally.
The company offers screening and discovery, nonclinical assessment stage, and clinical development stage services in the areas of chemical products, biologics, cell and gene therapeutics, radiopharmaceuticals, and traditional Chinese medicines.
The company was founded in 2010 and is based in Shanghai, China.
Shanghai InnoStar Bio-tech Co., Ltd.
| Country | China |
| Founded | 2010 |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| Employees | 1,092 |
| CEO | Yan Chang |
Contact Details
Address: No. 199, Guoshoujing Road Shanghai, 201203 China | |
| Phone | 86 21 5080 1259 |
| Website | innostar.cn |
Stock Details
| Ticker Symbol | 688710 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Yan Chang Ph.D. | Chief Executive Officer, President and Director |
| Xiaohong Gao | Vice President and Chief Financial Officer |
| Hua Li | Senior Vice President |
| Yan Li | Secretary to the Board |
| Fangjue Yao | Accounting Supervisor |
| Dr. Sean Xiaochun Chen Ph.D. | CSO |